Trials / Not Yet Recruiting
Not Yet RecruitingNCT04990336
Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis
Comparison of Clinical Efficacy of Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 306 (estimated)
- Sponsor
- Fifth Affiliated Hospital, Sun Yat-Sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A large number of clinical studies have shown that oral administration, external application or enema of Chinese medicine can promote the recovery of gastrointestinal function and the absorption of pancreatic inflammation. The aims of the study is to explore the application of Dachaihu Decoction Compound (DDC)and Rhubarb Single Medicine (RSM) in the Treatment of Acute Pancreatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Dachaihu decoction compound | Dachaihu decoction compound includes Bupleurum, Rhubarb, Citrus aurantium, Scutellaria, Pinellia, White Peony, Jujube, Ginger. |
| DRUG | Rhubarb single medicine | Rhubarb single medicine |
| COMBINATION_PRODUCT | Regular therapies | Regular therapies, such as fluid therapy, for acute pancreatitis |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2029-01-31
- Completion
- 2029-07-31
- First posted
- 2021-08-04
- Last updated
- 2022-03-24
Source: ClinicalTrials.gov record NCT04990336. Inclusion in this directory is not an endorsement.